Acasti Pharma Announces Year End Results and Corporate Reorganization

5/25/2012 9:55:36 AM

LAVAL, Quebec, May 25, 2012 (GLOBE NEWSWIRE) -- Acasti Pharma ("Acasti" or the "Corporation") (TSX-V:APO), a Neptune Technologies & Bioressources Inc's ("Neptune") subsidiary, reports the highlights of its financial results for the fiscal year ended February 29, 2012, provides a review of the year's most significant milestones and discusses its corporate reorganization.

Read at GlobeNewswire

Read Article at

Related Companies

News Categories

• GlobeNewswire

• Acasti Pharma

• Biotech/Pharma - Personnel

• Biotech/Pharma - Industry